Literature DB >> 11510705

Cellular proliferation in the female lower urinary tract with reference to oestrogen status.

P J Blakeman1, P Hilton, J N Bulmer.   

Abstract

OBJECTIVE: To assess cell proliferation throughout the tissues of the female lower urinary tract and to compare cell proliferation rates in women of varying oestrogen status.
DESIGN: Prospective observational study.
SETTING: A large teaching hospital. SAMPLE: Fifty-nine women undergoing surgery for urogynaecological conditions of whom 23 were premenopausal, 20 were postmenopausal and taking no oestrogen supplementation and 16 were postmenopausal and receiving some form of hormone replacement therapy. Biopsies were taken during surgery from the bladder dome, trigone, the proximal and distal urethra, vagina and vesico-vaginal fascia in the region of the bladder neck.
METHODS: Formalin-fixed paraffin-embedded biopsies were labelled by an avidin-biotin technique with a monoclonal antibody raised against part of the nuclear matrix known as Ki-67 antigen. MAIN OUTCOME MEASURES: Ki-67 expression was assessed in the epithelial, subepithelial and muscle or deep fascial regions of all tissues and related to oestrogen status.
RESULTS: Ki-67 expression was only found in high levels in biopsies containing squamous epithelia. Significantly higher levels of Ki-67 expression were observed in the tissues of oestrogen replete women in the premenopausal and hormone replacement groups, compared with postmenopausal women receiving no oestrogen supplementation.
CONCLUSIONS: Squamous epithelia of the female lower urinary tract exhibit greater levels of cell proliferation in oestrogen replete as compared with oestrogen deficient women. As these same squamous epithelia also consistently express oestrogen receptors, the findings suggest a mechanism by which oestrogen exerts its effect on the lower urinary tract and also provide an explanation for the success of oestrogen in the treatment of some conditions causing lower urinary tract dysfunction in postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11510705     DOI: 10.1111/j.1471-0528.2001.00210.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  16 in total

1.  Effect of prolonged use of high dose of tibolone on the vagina of ovariectomized rats.

Authors:  Helene Nara Henriques; Ana Carolina Bergmann de Carvalho; Porphirio José Soares Filho; José Augusto Soares Pantaleão; Maria Angélica Guzmán-Silva
Journal:  Int J Exp Pathol       Date:  2011-04-26       Impact factor: 1.925

Review 2.  Addressing the need for a simpler algorithm for the management of women with urinary incontinence.

Authors:  Lars Viktrup
Journal:  MedGenMed       Date:  2005-08-01

3.  Bladder cancer and reproductive factors among women in Spain.

Authors:  An-Tsun Huang; Manolis Kogevinas; Debra T Silverman; Nuria Malats; Nathaniel Rothman; Adonina Tardón; Consol Serra; Reina García-Closas; Alfredo Carrato; Kenneth P Cantor
Journal:  Cancer Causes Control       Date:  2009-12       Impact factor: 2.506

4.  Vaginal thickness, cross-sectional area, and perimeter in women with and those without prolapse.

Authors:  Yvonne Hsu; Luyun Chen; John O L Delancey; James A Ashton-Miller
Journal:  Obstet Gynecol       Date:  2005-05       Impact factor: 7.661

5.  Effects of vaginal conjugated equine estrogens and ospemifene on the rat vaginal wall and lower urinary tract.

Authors:  P Antonio Maldonado; T Ignacio Montoya; Jesus F Acevedo; Patrick W Keller; R Ann Word
Journal:  Biol Reprod       Date:  2017-01-01       Impact factor: 4.285

Review 6.  Pharmacotherapy for stress urinary incontinence : present and future options.

Authors:  Norman R Zinner; Stephanie C Koke; Lars Viktrup
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Effects of soy isoflavones on the uterus and urethra of ovariectomized rats.

Authors:  Elaine Travaglia Santos; Maria Dione Dutra Sampaio; Paulo Roberto Cecon; Manuel de Jesus Simões; Marair Gracio Ferreira Sartori; Manoel João Batista Castello Girão
Journal:  Int Urogynecol J       Date:  2009-10-09       Impact factor: 2.894

8.  Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.

Authors:  Suraj Konnath George; Veronica Tovar-Sepulveda; Steven S Shen; Weiguo Jian; Yiqun Zhang; Susan G Hilsenbeck; Seth P Lerner; Carolyn L Smith
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

9.  The mysteries of menopause and urogynecologic health: clinical and scientific gaps.

Authors:  Marianna Alperin; Lindsey Burnett; Emily Lukacz; Linda Brubaker
Journal:  Menopause       Date:  2019-01       Impact factor: 2.953

Review 10.  Overactive bladder in the female patient: the role of estrogens.

Authors:  Dudley Robinson; Linda Cardozo
Journal:  Curr Urol Rep       Date:  2002-12       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.